57516-101-02 : NDC 2026 Code

57516-101-02 : Alpha-1-proteinase Inhibitor Human Kit ( Zemaira )

Additionally :

You can get information about “57516-101-02” NDC code in 57516-101-02 in HTML format

HTML | 57516-101-02 in TXT (Plain Text) format

TXT | 57516-101-02 in PDF (Portable Document Format)

PDF | 57516-101-02 in XML format

XML formats.

NDC Code : 57516-101-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "57516-101-02",
    "PackageDescription": "1 KIT in 1 CARTON (57516-101-02)  *  20 mL in 1 VIAL, SINGLE-DOSE (57516-102-01)  *  20 mL in 1 VIAL, SINGLE-DOSE (57516-103-20) ",
    "NDC11Code": "57516-0101-02",
    "ProductNDC": "57516-101",
    "ProductTypeName": "PLASMA DERIVATIVE",
    "ProprietaryName": "Zemaira",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Alpha-1-proteinase Inhibitor Human Kit",
    "DosageFormName": "KIT",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20220222",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA125078",
    "LabelerName": "Fisher Clinical Services Inc.",
    "SubstanceName": null,
    "StrengthNumber": null,
    "StrengthUnit": null,
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-04-03",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220222",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}